
    
      Randomized control method was used to observe the clinical efficacy of the treatment of
      postmenopausal osteoporosis (kidney deficiency and blood stasis syndrome) with jiujian jiangu
      granules, combined with the gene expression of bone metabolism markers BALP, PINP, TRACP and
      S-CTX, and RANK, RANKL and OPG Detection, compared with the control group of ossification
      trihydrate capsules, to explore the mechanism of the treatment of postmenopausal osteoporosis
      by the continued Xulin Jiangu granules, and lay the foundation for the development of new
      drugs.
    
  